verapamil has been researched along with Hyperparathyroidism, Secondary in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with chronic renal failure (CRF) display impaired phagocytosis by the polymorphonuclear leucocytes (PMNL), and these cells have elevated basal levels of cytosolic calcium ([Ca2+]i) and reduced ATP content." | 1.28 | Impaired phagocytosis in chronic renal failure is mediated by secondary hyperparathyroidism. ( Alexiewicz, JM; Chervu, I; Fadda, GZ; Kiersztejn, M; Massry, SG; Smogorzewski, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, YB | 1 |
| Smogorzewski, M | 3 |
| Ni, Z | 1 |
| Massry, SG | 4 |
| Chervu, I | 1 |
| Kiersztejn, M | 1 |
| Alexiewicz, JM | 1 |
| Fadda, GZ | 3 |
| Hajjar, SM | 1 |
| Zayed, MA | 1 |
| Akmal, M | 1 |
| Soliman, AR | 1 |
| Lipson, LG | 1 |
4 other studies available for verapamil and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Altered cytosolic calcium homeostasis in rat cardiac myocytes in CRF.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium-Transporting ATPases; Carrier Proteins; Cytosol; H | 1994 |
Impaired phagocytosis in chronic renal failure is mediated by secondary hyperparathyroidism.
Topics: Animals; Calcium; Hyperparathyroidism, Secondary; In Vitro Techniques; Kidney Failure, Chronic; Male | 1992 |
Effect of chronic renal failure on Ca2+ ATPase of brain synaptosomes.
Topics: Animals; Brain; Ca(2+) Mg(2+)-ATPase; Calcium; Calcium-Transporting ATPases; Hyperparathyroidism, Se | 1991 |
Correction of glucose intolerance and the impaired insulin release of chronic renal failure by verapamil.
Topics: Animals; Calcium Channels; Glucose; Hyperparathyroidism, Secondary; Insulin; Insulin Secretion; Isle | 1989 |